Post-IPO Equity - Achillion Pharmaceuticals
Investment Firm
Overview
A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.
Announced Date
Feb 12, 2015
Closed on Date
Feb 19, 2015
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Achillion Pharmaceuticals raised $132700000 on 2015-02-12 in Post-IPO Equity
A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 22, 2011 |  Post-IPO Equity - Achillion Pharmaceuticals | - | 60.9M | |
| Feb 27, 2013 | Post-IPO Equity - Achillion Pharmaceuticals | - | 133.5M | |
| Jan 28, 2002 | Venture Round - Achillion Pharmaceuticals | 10 | - | 41.0M |
| Aug 18, 2010 | Post-IPO Equity - Achillion Pharmaceuticals | 4 | - | 50.1M |